Botulinum Toxin A in the treatment of frostbite sequelae - results from a blinded, early-phase, comparative trial.

This pilot study showed the study methodology with minor adjustments is feasible in a future full-scale clinical trial. The recruitment process needs to be more refined to ensure that the eligible study participants are a homogenous group of FCI patients.